Crohn's Disease
Crohn's disease is a type of inflammatory bowel disease (IBD) that causes inflammation of the digestive tract, leading to symptoms like abdominal pain, severe diarrhea, fatigue, and weight loss.
We are exploring how well a drug called adalimumab spreads in inflamed tissues using advanced imaging technology. This study aims to improve our understanding of drug distribution in patients with inflammatory bowel disease and rheumatoid arthritis.
Health conditions and diseases that the clinical trial is designed to study and treat.
Crohn's disease is a type of inflammatory bowel disease (IBD) that causes inflammation of the digestive tract, leading to symptoms like abdominal pain, severe diarrhea, fatigue, and weight loss.
Spondyloarthritis is a group of inflammatory diseases that primarily affect the spine and joints, causing pain and stiffness, particularly in the lower back and hips.
Rheumatoid arthritis (RA) is an autoimmune disorder that causes chronic inflammation of the joints, leading to pain, swelling, and potential joint damage over time.
Ulcerative colitis is a chronic inflammatory bowel disease that causes inflammation and ulcers in the lining of the colon, resulting in symptoms like abdominal pain and diarrhea.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.